A detailed history of Wms Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wms Partners, LLC holds 6,338 shares of BMY stock, worth $343,392. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,338
Previous 5,494 15.36%
Holding current value
$343,392
Previous $297,000 11.45%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $33,971 - $44,723
844 Added 15.36%
6,338 $263,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $161,692 - $183,328
-3,370 Reduced 38.02%
5,494 $297,000
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $127,211 - $151,798
-2,624 Reduced 22.84%
8,864 $454,000
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $115,606 - $129,265
-1,997 Reduced 14.81%
11,488 $666,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $92,188 - $102,360
-1,447 Reduced 9.69%
13,485 $862,000
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $165,589 - $187,815
-2,520 Reduced 14.44%
14,932 $1.03 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $325,006 - $384,853
-4,746 Reduced 21.38%
17,452 $1.26 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $722 - $427,230
-5,560 Reduced 20.03%
22,198 $1.58 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $79,518 - $87,578
-1,095 Reduced 3.8%
27,758 $2.14 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $28,772 - $34,500
468 Added 1.65%
28,853 $2.11 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $120,131 - $140,044
-2,240 Reduced 7.31%
28,385 $1.77 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $109,346 - $128,084
1,848 Added 6.42%
30,625 $1.81 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $37,517 - $40,856
-606 Reduced 2.06%
28,777 $1.92 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $19,582 - $22,024
-330 Reduced 1.11%
29,383 $1.86 Million
Q4 2020

Feb 17, 2021

BUY
$57.74 - $65.43 $45,730 - $51,820
792 Added 2.74%
29,713 $1.84 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $33,366 - $36,974
581 Added 2.05%
28,921 $1.74 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $1.22 Million - $1.42 Million
22,182 Added 360.21%
28,340 $1.67 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $185 - $269
4 Added 0.06%
6,158 $343,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $24,605 - $32,095
500 Added 8.84%
6,154 $395,000
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $49,399 - $58,570
1,155 Added 25.67%
5,654 $287,000
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $24,719 - $27,334
-554 Reduced 10.96%
4,499 $204,000
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $43,766 - $52,186
-970 Reduced 16.1%
5,053 $241,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $14,920 - $19,348
-306 Reduced 4.83%
6,023 $313,000
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $220 - $249
4 Added 0.06%
6,329 $393,000
Q2 2018

Aug 09, 2018

SELL
$50.53 - $62.98 $8,640 - $10,769
-171 Reduced 2.63%
6,325 $350,000
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $19,414 - $22,349
324 Added 5.25%
6,496 $411,000
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $4,795 - $5,228
-80 Reduced 1.28%
6,172 $378,000
Q3 2017

Oct 27, 2017

SELL
$55.23 - $63.74 $1,988 - $2,294
-36 Reduced 0.57%
6,252 $399,000
Q2 2017

Aug 09, 2017

BUY
N/A
6,288
6,288 $350,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wms Partners, LLC Portfolio

Follow Wms Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.